Gossamer Bio, Inc.
GOSS
$1.08
-$0.015-1.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 31.40% | 23.01% | 215.85% | 14.72% | 13.66% |
| Total Depreciation and Amortization | 6.86% | 0.92% | -13.81% | -13.51% | -10.42% |
| Total Amortization of Deferred Charges | -22.73% | -27.55% | -5.03% | -16.76% | 14.07% |
| Total Other Non-Cash Items | -85.65% | -63.02% | -70.06% | -53.41% | 20.64% |
| Change in Net Operating Assets | -678.23% | -5,361.04% | 1,714.65% | -23.53% | 126.09% |
| Cash from Operations | -6.15% | 7.13% | 404.17% | 1.30% | 29.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 470.43% | 77.38% | -556.96% | 607.10% | -267.71% |
| Cash from Investing | 470.43% | 77.38% | -556.96% | 607.10% | -269.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | -233.26% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -99.86% | -- | -5.18% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | -99.86% | -217.29% | -0.75% | -1.04% |
| Foreign Exchange rate Adjustments | -164.77% | 168.38% | 57.89% | -186.11% | -69.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.87% | -228.08% | 270.03% | 114.45% | -21.68% |